Rare Disease, Premium Price: Navigating the High-Value Economics...

added blog Health

2025-11-04 10:19:56 -

Rare Disease, Premium Price: Navigating the High-Value Economics and Reimbursement Challenges in the HAE Drug Landscape.

Hereditary Angioedema (HAE) falls squarely into the category of "orphan diseases"—rare conditions affecting a small percentage of the population. While the patient pool is limited, the economic structure of the HAE therapeutics market is defined by exceptionally high-value economics, driven by the premium pricing power afforded to orphan drugs. Developing drugs for rare diseases involves...

0 Comments 0 Shares 410 Views 0 Reviews